Lovaza
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
181 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypertriglyceridemia | D015228 | EFO_0004211 | — | 5 | 6 | 12 | 14 | 6 | 41 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | 2 | 4 | 4 | 3 | 12 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | 1 | 5 | 1 | 3 | 10 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 1 | 1 | 1 | 3 | 2 | 8 |
| Inflammation | D007249 | MP_0001845 | — | 1 | 3 | — | 1 | 3 | 8 |
| Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | — | 2 | 3 | 2 | 7 |
| Hyperlipidemias | D006949 | EFO_0003774 | E78.5 | 1 | — | 1 | 2 | 2 | 6 |
| Liver diseases | D008107 | EFO_0001421 | K70-K77 | 2 | 1 | 1 | 2 | 1 | 6 |
| Hiv infections | D015658 | EFO_0000764 | B20 | — | 1 | — | 5 | — | 6 |
| Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | 1 | 1 | 1 | 2 | — | 5 |
Show 31 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Myocardial infarction | D009203 | EFO_0000612 | I21 | 1 | 1 | 3 | — | 3 | 7 |
| Infarction | D007238 | EFO_0009463 | — | 1 | 1 | 3 | — | 3 | 7 |
| Coronary disease | D003327 | — | — | — | — | 1 | — | 3 | 4 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | — | — | 3 | — | 1 | 4 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | — | 2 | — | 1 | 3 |
| Heart failure | D006333 | EFO_0003144 | I50 | — | 1 | 3 | — | — | 3 |
| Asthma | D001249 | EFO_0000270 | J45 | — | — | 1 | — | 1 | 2 |
| Hyperlipoproteinemia type ii | D006938 | EFO_0004911 | E78.00 | — | — | 1 | — | 1 | 2 |
| Sudden death cardiac | D016757 | EFO_0004278 | — | — | — | 2 | — | — | 2 |
| Peripheral arterial disease | D058729 | EFO_0004265 | — | — | — | 1 | — | 1 | 2 |
Show 18 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 4 | 6 | — | — | 3 | 12 |
| Depression | D003863 | — | F33.9 | — | 2 | — | — | 2 | 4 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 2 | 3 | — | — | — | 3 |
| Colorectal neoplasms | D015179 | — | — | 1 | 3 | — | — | — | 3 |
| Carcinoma | D002277 | — | C80.0 | 2 | 3 | — | — | — | 3 |
| Lung neoplasms | D008175 | — | C34.90 | 1 | 3 | — | — | — | 3 |
| Depressive disorder | D003866 | EFO_1002014 | F32.A | — | 1 | — | — | 2 | 3 |
| Syndrome | D013577 | — | — | 1 | 2 | — | — | 1 | 3 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | 1 | — | — | 1 | 2 |
| Wasting syndrome | D019282 | — | — | — | 1 | — | — | 1 | 2 |
Show 45 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 2 | — | — | — | 3 | 5 |
| Ischemic stroke | D000083242 | — | — | 1 | — | — | — | — | 1 |
| Ischemia | D007511 | EFO_0000556 | — | 1 | — | — | — | — | 1 |
| Transient ischemic attack | D002546 | EFO_0003764 | G45.9 | 1 | — | — | — | — | 1 |
| Pancreatitis | D010195 | EFO_0000278 | K85 | 1 | — | — | — | — | 1 |
| Dermatitis | D003872 | — | L30.9 | 1 | — | — | — | — | 1 |
| Blister | D001768 | — | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Keratoconjunctivitis sicca | D007638 | EFO_1000906 | — | — | — | — | — | 3 | 3 |
| Dry eye syndromes | D015352 | — | H04.12 | — | — | — | — | 3 | 3 |
| Bone fractures | D050723 | EFO_0003931 | T14.8 | — | — | — | — | 2 | 2 |
| Bone density | D015519 | EFO_0003923 | M85 | — | — | — | — | 2 | 2 |
| Eye diseases | D005128 | EFO_0003966 | H44 | — | — | — | — | 2 | 2 |
| Chest pain | D002637 | — | R07.9 | — | — | — | — | 1 | 1 |
| Fertility | D005298 | — | — | — | — | — | — | 1 | 1 |
| Pain | D010146 | EFO_0003843 | R52 | — | — | — | — | 1 | 1 |
| Hepatitis c | D006526 | — | B19.2 | — | — | — | — | 1 | 1 |
| Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | — | — | — | — | 1 | 1 |
Show 20 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use